Gapping down
In reaction to disappointing earnings/guidance:
- BTI -1.1%, (provides H1 trading update)
Select metals/mining stocks trading lower:
- GFI -1.3%, BHP -1%, BBL -0.9%, MT -0.7%, GOLD -0.7%, GDX -0.6%
Other news:
- IDRA -14.5% (announces results from the Phase 2 clinical trial of IMO-8400 in adult patients with dermatomyositis)
- IMMU -4.3% (commenced an underwritten public offering of $275,000,000 of shares of its common stock)
- HTGC -3.4% (commences 6 mln common stock offering)
- MEDP -2.6% (prices secondary offering of 3 mln shares of its common stock by selling shareholders at $42.25 per share)
- HCC -1.7% (secondary offering of 4 mln shares of common stock by selling shareholders)
- HOME -1.6% (secondary offering of 8.0 mln shares of common stock)
- FBC -0.5% (prices secondary offering of 8 mln shares of common stock at $34.50 per share)
Analyst comments:
- SEAS -8.6% (downgraded to Sell from Neutral at Citigroup)
- BPL -2.8% (downgraded to Neutral from Buy at UBS)
- TRGP -1.3% (downgraded to Equal Weight from Overweight at Barclays)
- BF.B -1.2% (downgraded to Sell from Hold at Societe Generale)
- ABX -1.1% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
![]()